project id: TCGA-CESC; case submitter id: TCGA-EK-A2GZ; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 8.0; spectrophotometer method: UV Spec; age at index: 64; days to birth: -23599; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1944; age at diagnosis: 23599; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 383.0; figo stage: Stage IIIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: Not Reported; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1099; initial weight: 40.0; oct embedded: false; preservation method: Unknown; sample id: 5686f844-be97-472d-8564-a35c3a3ebac2; sample submitter id: TCGA-EK-A2GZ-01A; portion id: 6469b5ba-c242-4ba3-8ac8-ee28ef3c4cbf; portion submitter id: TCGA-EK-A2GZ-01A-11; slide id: 1518ac4a-4b26-4f18-a6f7-573bf84884d9; slide submitter id: TCGA-EK-A2GZ-01A-01-TSA; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 65.0; percent tumor cells: 30.0; percent tumor nuclei: 98.0; section location: TOP;